Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
about
Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationshipsLethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.Mad2 overexpression promotes aneuploidy and tumorigenesis in miceGenetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modificationsPractical uses for ecdysteroids in mammals including humans: an updateModulations of cell cycle checkpoints during HCV associated diseasePathway-based classification of cancer subtypes.Molecular dynamics simulation on the conformational transition of the mad2 protein from the open to the closed state.Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerBUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.Mitotic chromosomal instability and cancer: mouse modelling of the human disease.Cancer chromosomal instability: therapeutic and diagnostic challenges.Kinesin family member 4A: a potential predictor for progression of human oral cancerBUB1 mediation of caspase-independent mitotic death determines cell fate.Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancerId-I stimulates cell proliferation through activation of EGFR in ovarian cancer cellsChromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatMechanisms of chromosomal instability.Studying chromosome instability in the mouse.MAD2 Expression in Ovarian Carcinoma: Different Expression Patterns and Levels among Various Types of Ovarian Carcinoma and Its Prognostic Significance in High-Grade Serous CarcinomaComplete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells.Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitroMitotic checkpoint function in the formation of gross chromosomal rearrangements in Saccharomyces cerevisiae.Therapeutic relevance of the protein phosphatase 2A in cancer.Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy.A cell-based assay for screening spindle checkpoint inhibitorsRole of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells.HAT cofactor Trrap regulates the mitotic checkpoint by modulation of Mad1 and Mad2 expressionAnaphase-Promoting Complex 7 is a Prognostic Factor in Human Colorectal Cancer.Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors.Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.Analysis of the role of GSK3 in the mitotic checkpoint
P2860
Q21195153-A2D87C53-DBD2-4138-B510-19EE1C3DAD66Q24564215-5D71123C-2FAC-4067-BB8C-60B76B796346Q24684680-2AF497A3-09A5-41C0-A879-286BFDC9BC85Q24800072-4BC9F158-377C-4150-A6F0-F07FAED5122FQ24806380-BD2960CA-039F-4ED1-AE2B-01636268BEBFQ27489574-8E83AF21-3F90-40D2-93F9-626E346B21C5Q30527843-54D0482D-655E-4C63-AC18-15E56846C550Q33580433-0D7A2657-494D-4AD4-A9EC-937F2ED7B937Q33689051-F40FB291-69AC-4E80-A13F-1DF47C1714E4Q33838181-A95E407B-EEAD-45B7-BC68-269F7EE45670Q33925102-EEBFC701-65A2-4677-A5D3-81401FA0182FQ33926467-F14FDB49-64F7-44F3-AE34-37499B034082Q34275721-DA41F126-495A-4B62-960C-01845F921F29Q35081235-6D62E335-5254-4382-B560-1A1F4A464B42Q36118820-7F90164A-BA70-4D69-89FC-4C2AF4DB8640Q36670959-A9092542-A8BD-4F3C-AE85-5AA4C4F74678Q36695270-17F07651-64D9-44A1-A793-545B02D7776DQ36944182-A89DF813-83A9-463D-8733-4829E01B3B9FQ37193068-115BE1DB-2EC1-4B90-B516-7ED5F746C167Q37245042-6AC6CA2E-89FB-4AE2-A020-71B964E62B63Q37316711-490D0832-C15A-499B-B960-28FA49492072Q37357807-FA2C000C-6C6D-45C1-B33F-0F2AE1C9DA7BQ37457681-DBDAA2E7-0B09-4DBE-A57A-84AABE04C658Q37619395-3D8917B7-BD8C-4703-A8AF-C696AD801273Q37641636-EF3422C8-A884-48C6-83A7-7455BC3A33A0Q38015243-74B631FC-1E07-4FFB-BCD0-72729A37C397Q39392895-087FE800-AC59-4786-8F91-BBDE19EC98C8Q40249347-8B1FECDD-80C2-44B0-A788-58BB47C815A5Q40619789-D77A4946-990C-414A-B0F7-E751CF38E97BQ41711221-7486D1B7-B58D-4D7A-84F3-395577246332Q41834181-C163E91E-2AC6-49AB-8ED3-34BB3B9B4ED2Q42180607-B1DC4EBA-3378-4319-B982-C414EAF27D00Q55638534-CE7E0B66-69EB-46BC-B9BC-6C1C358FC254Q58700295-131AF9CD-A82A-4DE6-A292-3ACCD28395B0
P2860
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
@en
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
@nl
type
label
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
@en
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
@nl
prefLabel
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
@en
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
@nl
P2093
P1433
P1476
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells
@en
P2093
Annie L M Cheung
Dong-Yan Jin
Huichen Feng
Raymond W M Ng
Sai W Tsao
Xianghong Wang
Yong C Wong
P304
P407
P577
2002-03-01T00:00:00Z